首頁(yè)
訂購(gòu)/客服:400-666-5481

PP242

    
95%

PP242

源葉(MedMol)
S80083 一鍵復(fù)制產(chǎn)品信息
1092351-67-1
C16H16N6O
308.34
PP 242;PP-242;2-(4-氨基-1-異丙基-1H-吡唑并[3,4-d]嘧啶-3-基)-1H-吲哚-5-醇
貨號(hào) 規(guī)格 價(jià)格 上海 北京 武漢 南京 購(gòu)買數(shù)量
S80083-2mg 95% ¥60.00 9 - - -
S80083-5mg 95% ¥90.00 6 - - -
S80083-10mg 95% ¥150.00 7 - - -
S80083-25mg 95% ¥350.00 5 - - -
S80083-50mg 95% ¥530.00 5 - - -
S80083-100mg 95% ¥1000.00 5 - - -
S80083-200mg 95% ¥1800.00 貨期:2-3天 - - -
產(chǎn)品介紹 參考文獻(xiàn) 質(zhì)檢證書(COA) 摩爾濃度計(jì)算器 相關(guān)產(chǎn)品

產(chǎn)品介紹

Torkinib (PP 242) is a selective and ATP-competitive mTOR inhibitor with an IC50 of 8 nM. PP242 inhibits both mTORC1 and mTORC2 with IC50s of 30 nM and 58 nM, respectively

產(chǎn)品描述: Torkinib (PP 242) is a selective and ATP-competitive mTOR inhibitor with an IC50 of 8 nM. PP242 inhibits both mTORC1 and mTORC2 with IC50s of 30 nM and 58 nM, respectively
靶點(diǎn): mTORC1:30 nM (IC50);mTORC2:58 nM (IC50);mTOR:8 nM (IC50);p110δ:100 nM (IC50);DNA-PK:410 nM (IC50);PDGFR:410 nM (IC50);p110α:2 μM (IC50);p110β:2.2 μM (IC50);p110γ:1.3 μM (IC50);Abl:3.6 μM (IC50);Hck:1.2 μM (IC50);Scr:1.4 μM (IC50);Scr(T338I):5.1 μM (IC50);VEGFR2:1.5 μM (IC50);EGFR:4.4 μM (IC50);EphB4:3.4 μM (IC50);Autophagy;Mitophagy;Apoptosis;Mitophagy;PI3K;mTOR;Autophagy
體內(nèi)研究: In fat and liver, Torkinib (PP 242) is able to completely inhibit the phosphorylation of Akt at S473 and T308, consistent with its effect on these phosphorylation sites observed in cell culture. Surprisingly, Torkinib (PP 242) is only partially able to inhibit the phosphorylation of Akt in skeletal muscle and is more effective at inhibiting the phosphorylation of T308 than S473, despite it's ability to fully inhibit the phosphorylation of 4EBP1 and S6. These results will be confirmed by in vivo dose-response experiments, but, consistent with the partial effect of Torkinib (PP 242) on pAkt in skeletal muscle, a muscle-specific knockout of the integral mTORC2 component rictor resulted in only a partial loss of Akt phosphorylation at S473. These results suggest that a kinase other than mTOR, such as DNA-PK, may contribute to phosphorylation of Akt in muscle
參考文獻(xiàn): 1. Apsel B, et al. Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol. 2008 Nov;4(11):691-9. 2. Feldman ME, et al. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 2009 Feb 10;7(2):e38.
溶解性: DMSO  :  50  mg/mL  (162.16  mM;  Need  ultrasonic)
保存條件: 2-8℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 3.243 ml 16.216 ml 32.432 ml
5 mM 0.649 ml 3.243 ml 6.486 ml
10 mM 0.324 ml 1.622 ml 3.243 ml
50 mM 0.065 ml 0.324 ml 0.649 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。

參考文獻(xiàn)

質(zhì)檢證書(COA)

如何獲取質(zhì)檢證書(COA)?
請(qǐng)輸入貨號(hào)和一個(gè)與之匹配的批號(hào)。
例如:
批號(hào):JS298415 貨號(hào):S20001-25g
在貨品標(biāo)簽上如何找到貨號(hào)和批號(hào)?

摩爾濃度計(jì)算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關(guān)產(chǎn)品